XPD gene polymorphism at position 751 in exon 23 (rs13181), resulting in a lysine-to-glutamine transition, may alter the interactions of different proteins, reduce the activity of TFIIH complexes and modulate genetic susceptibility to cancer. This evidence concerns the gene ERCC2 and cancer.